 |
| The First Word |  Top |
|
 |
|
Bovine Growth Hormone and Pork-Barrel Politics p963
Douglas K. McCormick
doi:10.1038/nbt0993-963
PDF
(124K)
|
|
| Correspondence | Top |
|
|
|
Agbio benefits and pitfalls p964
Roger Wrubel
& Sheldon Krimsky
doi:10.1038/nbt0993-964a
PDF
(105K)
|
|
|
|
Amicus and biotechnology pp964 - 966
Francesca Lyman
doi:10.1038/nbt0993-964b
PDF
(216K)
|
|
|
|
Transgenic animal experiments p966
Jo Towell
doi:10.1038/nbt0993-966
PDF
(124K)
|
|
| Commentary | Top |
|
|
|
Unsolved Mysteries p968
Bernard Dixon
doi:10.1038/nbt0993-968
PDF
(117K)
|
|
| News Analysis | Top |
|
|
|
U.S. lags in nutriceutical development pp969 - 972
Lantz Miller
doi:10.1038/nbt0993-969
PDF
(244K)
|
|
|
|
FDA advisory panel okays Genentech's DNase pp972 - 973
Ray Potter
doi:10.1038/nbt0993-972
PDF
(247K)
|
|
|
|
Biotreatment firms rush to marketplace pp973 - 975
Joseph Alper
doi:10.1038/nbt0993-973
PDF
(479K)
|
|
|
|
Going gets weird with BST and Wildlands Project pp978 - 979
Russ Hoyle
doi:10.1038/nbt0993-978
PDF
(243K)
|
|
|
|
Impacting biological weapons p979
Jeffrey L. Fox
doi:10.1038/nbt0993-979
PDF
(131K)
|
|
|
|
Analyzing the U.S. corn-genetics business p980
George Kidd
doi:10.1038/nbt0993-980
PDF
(135K)
|
|
|
|
Telor Ophthalmic is second quarter's sole IPO p982
Claire M. Corcoran
doi:10.1038/nbt0993-982a
PDF
(125K)
|
|
|
|
Human gene sequencing makes advances p982
Joseph Alper
doi:10.1038/nbt0993-982b
PDF
(125K)
|
|
|
|
Analysts assess biopharmaceutical firms pp986 - 987
B. J. Spalding
doi:10.1038/nbt0993-986
PDF
(1,025K)
|
|
|
|
Corporate communications are worth a million p988
David Stone
doi:10.1038/nbt0993-988
PDF
(125K)
|
|
|
|
Product Update p989
Mark Goodstein
doi:10.1038/nbt0993-989
PDF
(105K)
|
|
|
|
Alliance Update p992
Mark Goodstein
doi:10.1038/nbt0993-992
PDF
(121K)
|
|
| Articles | Top |
|
|
|
1993 Bio/Technology Compensation Survey pp994 - 996
Douglas K. McCormick
& Mark Goodstein
doi:10.1038/nbt0993-994
Abstract | PDF
(2,915K)
|
|
|
|
Biotherapies and B-Cell Differentiation pp998 - 1000
Stephen M. Edgington
doi:10.1038/nbt0993-998
Abstract + references | PDF
(371K)
|
|
|
|
Does Biotechnology Measure Up? pp1003 - 1006
John Hodgson
& Kirsty Barlow
doi:10.1038/nbt0993-1003
Abstract | PDF
(1,254K)
|
|
| Review | Top |
|
|
|
In Situ Product Removal as a Tool for Bioprocessing pp1007 - 1012
Amihay Freeman, John M. Woodley
& Malcolm D. Lilly
doi:10.1038/nbt0993-1007
Abstract + references | PDF
(885K)
|
|
| Case Study in Product Development | Top |
|
|
|
Recombinant Human Thyroid Stimulating Hormone: Development of a Biotechnology Product for Detection of Metastatic Lesions of Thyroid Carcinoma pp1014 - 1024
Edward S. Cole, Karen Lee, Kevin Lauziere, Christine Kelton, Scott Chappel, Bruce Weintraub, Dawn Ferrara, Pamela Peterson, Rick Bernasconi, Tim Edmunds, Susan Richards, Lydia Dickrell, James M. Kleeman, John M. McPherson
& Bruce M. Pratt
doi:10.1038/nbt0993-1014
Abstract + references | PDF
(1,822K)
|
|
| Research | Top |
|
|
|
Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions pp1026 - 1030
Russell Higuchi, Carita Fockler, Gavin Dollinger
& Robert Watson
doi:10.1038/nbt0993-1026
Abstract + references | PDF
(1,020K)
|
|
|
|
Soluble Forms of the Human T Cell Receptor CD4 are Efficiently Expressed by Streptomyces lividans pp1031 - 1036
James A. Fornwald, Mary Jo Donovan, Robert Gerber, John Keller, Dean P. Taylor, Edward J. Arcuri
& Mary E. Brawner
doi:10.1038/nbt0993-1031
Abstract + references | PDF
(1,012K)
|
|
|
|
High Level, Stable Production of Recombinant Proteins in Mammalian Cell Culture using the Herpesvirus VP16 Transactivator pp1037 - 1041
Paul Hippenmeyer
& Maureen Highkin
doi:10.1038/nbt0993-1037
Abstract + references | PDF
(711K)
|
|
|
|
A Reverse Transcriptase-Polymerase Chain Reaction Assay for the Detection and Quantitation of Murine Retroviruses pp1042 - 1046
John M. Irving, Lucille W. S. Chang
& Francisco J. Castillo
doi:10.1038/nbt0993-1042
Abstract + references | PDF
(745K)
|
|
|
|
Transgenic Potato Plants Expressing Mammalian 2'−5' Oligoadenylate Synthetase are Protected From Potato Virus X Infection Under Field Conditions pp1048 - 1052
Erkki Truve, Anu Aaspôllu, Jarmo Honkanen, Reetta Puska, Merja Mehto, Anja Hassi, Teemu H. Teeri, Merike Kelve, Pauli Seppänen
& Mart Saarma
doi:10.1038/nbt0993-1048
Abstract + references | PDF
(975K)
|
|
| Book Review | Top |
|
|
|
Highly Readable, Seriously Flawed pp1053 - 1054
Bernard Dixon
doi:10.1038/nbt0993-1053
PDF
(708K)
|
|
| Biotools | Top |
|
|
|
Biotechnology Patent Protection in Japan pp1056 - 1058
Elizabeth F. Enayati
doi:10.1038/nbt0993-1056
Abstract | PDF
(675K)
|
|
|
|
Expanded Bed Adsorption p1059
Douglas K. McCormick
doi:10.1038/nbt0993-1059
Abstract | PDF
(112K)
|
|
| Bio Q&A | Top |
|
|
|
Chromatography: Separation and Purification pp1061 - 1062
John Hodgson
doi:10.1038/nbt0993-1061
PDF
(216K)
|
|
| Reader Service | Top |
|
|
|
| New Products |
|
|
|
New Products p1064
doi:10.1038/nbt0993-1064
PDF
(149K)
|
|
 |
|
| Chromatography |
|
|
|
Chromatography pp1065 - 1066
doi:10.1038/nbt0993-1065
PDF
(274K)
|
|
|
|
| Free Literature |
|
|
|
Free Literature pp1067 - 1068
doi:10.1038/nbt0993-1067
PDF
(483K)
|
|
| The Last Word | Top |
|
|
|
Perception of Biotechnology Risks: The Emotional Dimension pp1075 - 1076
Henry I. Miller
doi:10.1038/nbt0993-1075
PDF
(221K)
|
|
|
Top |
|
|
